FDA Inspection 1040075 — Noven Pharmaceuticals, Inc.

Noven Pharmaceuticals, Inc. — FEI 1000222037

The FDA completed an inspection of Noven Pharmaceuticals, Inc. on Jan 26, 2018 in Miami, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 26, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Miami, FL (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.